Artificial Intelligence and Digital Health in Gastroenterology
Researchers are invited to submit abstracts for the "Artificial Intelligence and Digital Health in Gastroenterology" track at GASTROENTEROLOGY-2024. This track will explore the transformative impact of artificial intelligence (AI) and digital health technologies on the field of gastroenterology.
Abstract submissions should focus on AI applications in gastrointestinal imaging interpretation, predictive analytics for disease management, automated endoscopic quality assessment, and personalized treatment algorithms. We welcome studies on digital health innovations such as telemedicine platforms, mobile health apps, and wearable devices for remote patient monitoring.
What to Expect:
Attendees can expect enlightening sessions featuring expert presentations on the integration of AI into clinical practice, real-world applications of digital health tools, and regulatory considerations in AI-driven diagnostics. The track will explore collaborative efforts between gastroenterologists, data scientists, and technology developers to harness AI's potential in improving patient outcomes and operational efficiency.
Join us at GASTROENTEROLOGY-2024 to explore the frontier of AI and digital health in gastroenterology, engage in discussions on ethical implications and future trends, and contribute to shaping the digital transformation of gastroenterological care.
Related Conference of Artificial Intelligence and Digital Health in Gastroenterology
25th International Conference on Gastroenterology and Digestive Disorders
Artificial Intelligence and Digital Health in Gastroenterology Conference Speakers
Recommended Sessions
- Artificial Intelligence and Digital Health in Gastroenterology
- Bariatric and Metabolic Surgery
- Biomarkers for Gastrointestinal Diseases
- Colorectal Cancer Screening and Surveillance
- Endoscopic Innovations in Gastrointestinal Disorders
- Functional Gastrointestinal Disorders (FGIDs)
- Gastrointestinal Motility Disorders
- Gastrointestinal Oncology
- Gut Microbiota and Digestive Health
- Hepatitis B and Hepatitis C
- Hepatocellular Carcinoma (HCC)
- Liver Fibrosis and Cirrhosis
- Liver Transplantation and Regenerative Medicine
- Microbiome and Liver Health
- Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
- Nutrition and Digestive Health
- Pediatric Gastroenterology
- Precision Medicine in Gastrointestinal Cancers
- Quality Improvement and Patient-Centered Care
- Therapeutic Advances in Inflammatory Bowel Disease (IBD)
Related Journals
Are you interested in
- Advances in Medical Imaging - Gastrosummit 2027 (France)
- Celiac Disease - Gastrosummit 2027 (France)
- Colorectal Diseases - Gastrosummit 2027 (France)
- Diagnostic Biomarkers and Therapeutic Targets in Digestive Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Digestive System Cancers - Gastrosummit 2027 (France)
- Digestive System Cancers - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Endoscopy and Minimally Invasive Gastrointestinal Procedures - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Esophageal Disorders - Gastrosummit 2027 (France)
- Esophageal Disorders - Gastrosummit 2027 (France)
- Gastric Diseases and Peptic Ulcers - Gastrosummit 2027 (France)
- Gastric Diseases and Peptic Ulcers - Gastrosummit 2027 (France)
- Gastrointestinal Bleeding - Gastrosummit 2027 (France)
- Gastrointestinal Disorders and Treatment - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Infections and Immunity - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology and Tumor Biology - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Pharmacology - Gastrosummit 2027 (France)
- Gastrointestinal Surgery - Gastrosummit 2027 (France)
- Geriatric Gastroenterology - Gastrosummit 2027 (France)
- Gut Microbiota and Gastrointestinal Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gut Microbiota and Metabolic Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Hepatology: Liver Disease and Transplantation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Disease (IBD) - Gastrosummit 2027 (France)
- Inflammatory Bowel Disease and Intestinal Inflammation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver and Pancreatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatology - Gastrosummit 2027 (France)
- Liver Transplantation - Gastrosummit 2027 (France)
- Non-Alcoholic Fatty Liver Disease - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Nutrition and Aging: Geriatric Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Nutrition in Digestive Health - Gastrosummit 2027 (France)
- Pancreatic Diseases - Gastrosummit 2027 (France)
- Pancreaticobiliary Disorders - Gastrosummit 2027 (France)
- Pediatric and Adolescent Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology - Gastrosummit 2027 (France)
- Pediatric Gastroenterology and Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Peptic Ulcer and Acid-related Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Plant-Based Nutrition and Sustainable Diets - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Precision Medicine in Digestive Diseases - Gastrosummit 2027 (France)
- Role of Microbiota in Digestive Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Viral Hepatitis - Gastrosummit 2027 (France)
